SCHEMBL8809972

SCHEMBL8809972

Cc1oncc1C(=O)Nc1ccc(C(=O)c2ccc(F)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.64
NPC1 O15118 4/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
CYP1A2 P05177 2/20 0.64
CYP2C9 P11712 2/20 0.64
LMNA P02545 2/20 0.64
GMNN O75496 1/20 0.64
TP53 P04637 1/20 0.64
CYP3A4 P08684 1/20 0.64
HTR1A P08908 1/20 0.64
THRB P10828 1/20 0.64
PIM1 P11309 1/20 0.64
MAOA P21397 1/20 0.64
SLC6A2 P23975 1/20 0.64
HTR2A P28223 1/20 0.64
AGTR1 P30556 1/20 0.64
CCKBR P32239 1/20 0.64
MC4R P32245 1/20 0.64
CYP2C19 P33261 1/20 0.64
THPO P40225 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11441650 0.93 RAB9A (0.72) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL8812469 0.89 RAB9A (0.64) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL8809733 0.88 RAB9A (0.66) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL8811232 0.87 RAB9A (0.61) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL8810729 0.87 RAB9A (0.61) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL11428900 0.86 RAB9A (0.88) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL8809677 0.85 RAB9A (0.58) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL8809721 0.84 DHODH (0.48) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL9116353 0.83 LTA4H (0.44) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9
SCHEMBL6230239 0.82 RAB9A (0.72) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527736-B1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS HOECHST AG (DE) 1997-04-16 EP disclosed
US-5532259-A ANTITUMOR HOECHST AKTIENGESELLSCHAFT (DE) 1996-07-02 US disclosed
US-5494911-A TREATING LEUKEMIA, SARCOMA, CARCINOMA, LYMPHOMA, SKIN CANCER HOECHST AKTIENGESELLSCHAFT (DE) 1996-02-27 US disclosed
EP-0527736-A1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS. HOECHST AG (DE) 1993-02-24 EP disclosed
WO-1991017748-A1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS HOECHST AKTIENGESELLSCHAFT (DE) 1991-11-28 WO disclosed